Synthio Labs, a clinical-grade voice AI company, has raised $5 million in its seed funding round led by Elevation Capital. The round also saw participation from 1984 Ventures, Peak XV Partners, Y Combinator, and several strategic angels from the global healthcare and AI ecosystem.
The funds raised will be used to expand its engineering and product teams, scale its presence in the US and Europe, and onboard more life sciences clients.
Founded in 2024 by Supreet Deshpande, Sahitya Sridhar, and Rajashekar Vasantha, Synthio Labs builds clinical-grade voice AI for communication between life sciences companies, clinicians, and patients.
Synthio Labs’ AI Operating System unifies three flagship platforms: Jarvis, the clinical-grade Voice AI copilot for field teams; Ather, the multimodal AI engine that powers seamless omnichannel engagement with physicians and patients; and Simulation Studio, the advanced insight platform that generates high-fidelity digital twins of clinicians and patients for research and strategy. Together, these products help life-sciences teams automate compliant conversations, capture structured intelligence at scale, and deliver consistent, human-grade experiences to every clinician and patient.
Early adopters include several of the Top 10 Pharma Cos and leading D2C healthcare brands who are using Synthio’s Voice AI to transform physician and patient engagement. In one project, Synthio’s Voice AI reached more than 5,000 eczema patients in 48 hours.
Supreet Deshpande, Co-founder and CEO of Synthio Labs, said, “Beyond breakthrough medicines, the future of healthcare will depend on how we reach and support every clinician and patient who relies on them.”
Rajashekar Vasantha, Co-founder and CTO, said, “At Synthio, we’re building the AI infrastructure that makes that possible – intelligently, compliantly, and at scale.”
Sahitya Sridhar, Co-founder and Chief Product Officer, said, “We’re designing products that make every conversation between pharma and their customers smarter, faster, and more meaningful. Healthcare is moving into a world of abundance. Our view is simple: bring consumer-grade experiences to pharma and empower the people delivering care.”
Krishna Mehra, AI Partner, Elevation Capital, said, “We believe Synthio Labs is defining the next major Customer Engagement infrastructure for Life Sciences. Their Clinical-grade Voice AI platform unifies how pharma communicates – giving field teams a powerful voice companion, and giving physicians and patients instant, trusted, compliant answers 24/7. Pharma’s global Commercial and GTM footprint is a trillion-dollar machine ripe for reinvention, and Synthio has exactly the right team to deliver on this mission.”
